Status:
COMPLETED
Exploring the Effects of a Baduanjin Program on the Symptoms of Constipation in Patients With Schizophrenia Spectrum
Lead Sponsor:
National Yang Ming Chiao Tung University
Collaborating Sponsors:
Tri-Service General Hospital
Conditions:
Randomized Controlled Trial
Eligibility:
All Genders
20-64 years
Phase:
NA
Brief Summary
Patients with schizophrenia spectrum have been suffering from constipation due to long-term use of psychotropic medications and changes in physical activity and eating habits caused by diseases. Aim ...
Detailed Description
This study was conducted in two psychiatric center. Residents in one of psychiatric center were allowed to walk for 20 min after dinner every day, and each unit residents rare active. In this study, p...
Eligibility Criteria
Inclusion
- Comply with the diagnosis of the spectrum.
- Have the willingness to participate in the study and could read, communicate and cooperate with the completion of the consent form and questionnaire.
- The age is 20 to 64 years old.
- No need for any assistance in walking, and the gait is stable.
- Appeared more than 2 times in the past month for more than 3 consecutive days without resolving or routine use of laxatives
Exclusion
- Diagnosis is organic brain disease, alcohol and substance abuse.
- There have been problems with gastrointestinal bleeding or lesions.
- Have a history of extensive abdominal surgery or gastrointestinal surgery.
- There are medical considerations and medical expenses reduction activities.
Key Trial Info
Start Date :
October 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT04071444
Start Date
October 8 2018
End Date
July 1 2019
Last Update
September 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Yang-Ming University
Taipei, Taiwan